Original Research
Published on 02 Oct 2023
Development and characterization of a prototypic pan-amyloid clearing agent – a novel murine peptide-immunoglobulin fusion
in Vaccines and Molecular Therapeutics

- 1,165 views
Original Research
Published on 02 Oct 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 02 Oct 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 27 Sep 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 27 Sep 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 26 Sep 2023
in Vaccines and Molecular Therapeutics

Review
Published on 25 Sep 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 22 Sep 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 20 Sep 2023
in Vaccines and Molecular Therapeutics

Editorial
Published on 19 Sep 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 18 Sep 2023
in Vaccines and Molecular Therapeutics

Clinical Trial
Published on 18 Sep 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 18 Sep 2023
in Vaccines and Molecular Therapeutics

Original Research
Published on 18 Sep 2023
in Vaccines and Molecular Therapeutics

Correction
Published on 15 Sep 2023
in Vaccines and Molecular Therapeutics
Correction
Published on 15 Sep 2023
in Vaccines and Molecular Therapeutics
Original Research
Published on 15 Sep 2023
in Vaccines and Molecular Therapeutics
